Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Postoperative Acute Kidney Injury Prevention in Hepatobiliary-Pancreatic Surgery
NCT07674719Not yet recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised trial of remimazolam in acute kidney injury (AKI) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Incidence of Acute Kidney Injury. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07674719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674719.